Usually, breast cancer development is associated with the amplification of cyclin D1 and its high expression, respectively, the high expression of cyclin E in 60% of breast tumors and a mitogenic effect of cyclin D1 exerted by an estrogen-dependent mechanism. Here, CCND1 is linked to breast carcinoma.